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1098-612X/08/010041+06 $32.00/0Bartonella henselae has been implicated as a causative agent of chronic uveitis in
people and in some cats. The objective of this study was to determine whether
Bartonella species seroprevalence or titer magnitude varies among cats with
uveitis, cats without ocular diseases recorded and healthy cats, while controlling
for age and risk of flea exposure based on state of residence. There was no
difference in seroprevalence rates or titer magnitude between cats with uveitis
and cats with non-ocular diseases. Healthy cats were more likely to be
seropositive for Bartonella species than cats with uveitis. The median Bartonella
species titer was 1:64 for all groups, although healthy cats were more likely to
have higher titers than cats with uveitis and cats with non-ocular disease. The
results suggest that serum antibody tests alone cannot be used to document
clinical uveitis associated with Bartonella species infection.Date accepted: 21 June 2007  2007 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved.A
nterior uveitis in cats can have endoge-
nous or exogenous causes (Powell and
Lappin 2001). Exogenous uveitis is the
result of an external influence on the eye, such
as trauma or surgery, and can generally be diag-
nosed based upon history and ophthalmic exam-
ination. Some causes of endogenous uveitis, such
as primary intraocular neoplasia or cataract, also
can be diagnosed by ophthalmic examination.
However, infectious or immune-mediated causes
are not so easily identified because of the lack of
adequate diagnostic tests. In these cases, a diagno-
sis of idiopathic uveitis is made. The infectious
agents commonly associated with endogenous
uveitis include feline infectious peritonitis virus
(Peiffer and Wilcock 1991), feline immunodefi-
ciency virus (FIV) (English et al 1990), feline leuke-
mia virus (FeLV) (Brightman et al 1991),
Toxoplasma gondii (Lappin et al 1992), felineherpes-
virus type 1 (FHV-1) (Maggs et al 1999), and sys-
temic mycoses (Gerding et al 1994, Medleau et al
1995). However, it is likely that other infectious
agents can also cause intraocular inflammation.mar.colostate.edu
ultant in Fort Collins.
 2007 ESFM aCats are the main reservoir for Bartonella hense-
lae and infection of cats and humans is extremely
common (Jackson et al 1993, Nutter et al 2004).
The organism replicates in endothelial cells,
persists within erythrocytes for months to years
and can result in a variety of chronic immune-
mediated reactions in the host (Kordick and
Breitschwerdt 1995, Resto-Ruiz et al 2003). Barto-
nella henselae is the most common cause of cat
scratch disease in people and has also been asso-
ciated with ocular inflammation in humans
(Rothova et al 1998, Ormerod and Dailey 1999,
Cunningham and Koehler 2000, Wade et al 2000).
The first published report of presumptive
feline ocular bartonellosis described a cat with
chronic anterior uveitis, B henselae antibodies in
serum, local (intraocular) production of B hense-
lae antibodies, and clinical improvement follow-
ing administration of doxycycline (Lappin and
Black 1999). In another report, serum and aque-
ous humor were collected from client-owned
cats with uveitis and cats without uveitis within
a humane society (Lappin et al 2000). Aqueous
humor was tested for anti-Bartonella species
IgM and IgG and the results compared to those
from the serum to determine whether intraocularnd AAFP. Published by Elsevier Ltd. All rights reserved.
42 JP Fontenelle et alproduction of antibodies against Bartonella spe-
cies was occurring. In addition, aqueous humor
was assayed for DNA from Bartonella species us-
ing a conventional polymerase chain reaction
(PCR) assay. Cats with uveitis and cats without
uveitis had B henselae DNA amplified from the
aqueous humor but only cats with uveitis had
intraocular production of antibodies against B
henselae. In another study, the authors docu-
mented serum antibody production against Bar-
tonella species via Western blot immunoassays
in cats with uveitis (Ketring et al 2004).
While Bartonella species are now considered by
some veterinary ophthalmologists to cause acute
and chronic uveitis in cats, the number of cats
with proven Bartonella species-associated uveitis
is minimal to date. Additional data are needed
to determine the importance of this disease syn-
drome in cats. The purpose of this study was to
compare Bartonella species serum antibody test
results among groups of cats with or without
uveitis.Materials and methods
Experimental design
An email was posted on the American College of
Veterinary Ophthalmologists list-serve request-
ing submission of serum and aqueous humor
samples from cats with endogenous uveitis for
free infectious disease agent testing. Samples
were collected from client-owned cats between
January 1, 2003 and January 1, 2004. Most cats
had been examined by a veterinary ophthalmol-
ogist and were suspected to have idiopathic or
infectious uveitis (group 1: cats with uveitis).
Samples were included whether or not treat-
ments had been administered and whether the
inflammation involved the anterior or posterior
uvea, or both. Samples were shipped by over-
night express on cold packs and, upon receipt,
were frozen at 70C until the serum was tested
in this study.
The records’ database in the Specialized
Infectious Diseases Laboratory at Colorado State
University was searched for feline serum sam-
ples tested over the same time period and then
sequentially selected based on availability of
adequate sample volume for additional testing
and presence of clinical illness without mention
of ocular disease (group 2: clinically ill cats with-
out ocular disease noted). Group 3 (healthy cats)
consisted of sequentially selected, healthy cats
for which adequate sample was available foradditional testing. Samples were collected be-
tween April 1, 1998 and April 1, 2000. Age, sex,
and geographical location (state in the USA)
were recorded for each case. Each sample had
been previously submitted for infectious disease
testing. The most commonly requested tests in-
cluded Toxoplasma gondii, FeLV, FIV, and corona-
virus. The samples had been stored at 20C
or 80C until used in this study.
All samples were thawed and assayed in an
IgG enzyme-linked immunosorbent assay (ELISA)
for the detection of antibodies against B henselae
(Lappin et al 2000). A 1:64 dilution of positive
control, negative control, and suspect sera were
each assayed in quadruplicate wells and the mean
absorbencies calculated. Mean absorbance values
were converted to %ELISA units by use of the
following formula: (test sample mean absorbance
minus the negative control sample mean absor-
bance)/(positive control sample mean absor-
bance minus the negative control sample mean
absorbance) multiplied by 100. An individual
cat was considered positive for B henselae anti-
bodies if the %ELISA value was greater than
the mean %ELISA value plus 3SD of the pre-
inoculation samples for a group of 26 specific
pathogen-free cats (10 kittens at 8 weeks of age
and 16 cats at 3 years of age). Positive suspect se-
rum sample results were converted to estimated
titers ranging from 1:64 to 1:4096 by comparing
to a standard curve.Statistical evaluation
Age, flea risk, clinical manifestation and B hense-
lae titer were entered into a spreadsheet and an-
alyzed by use of a commercially available
statistical software package (SAS, SAS Institute,
Cary, NC, version 9.1). Whether or not cats in
this study had been exposed to Ctenocephalides
feliswas unknown. Therefore, cats were classified
as having ‘high’ or ‘low’ flea risk based upon
state of origin (Jameson et al 1995). Cats from
the following geographic areas (states) were
categorized as having low risk of flea exposure:
Alaska, Arizona, Colorado, Idaho, Montana,
Nevada, New Mexico, Utah, and Wyoming.
Cats from all other states were considered to
have a high risk of flea exposure. Relationships
between B henselae serological status (positive
or negative) and clinical presentations were first
assessed by Fisher’s exact test. Additionally,
logistic regression was used to assess the influ-
ence of serological status, age, and risk of flea
exposure on clinical presentation. Cats were
Table 2. Influence of clinical presentation (group),
risk of flea exposure and age on serological
status
Effect P value
Group 0.0126
Flea-risk <0.0001
Age class* 0.0035
43Prevalence of serum antibodies against Bartonella speciesgrouped into five age classes of approximately
equal sample sizes (<2, 2 to <5, 5 to <8, 8 to
<11, and 11 years of age). Relationships be-
tween B henselae titer magnitude and clinical
manifestations were assessed by determining
median titers for each group and evaluated
with Wilcoxon’s rank sum test. Significance was
defined as P< 0.05.*Cats were grouped into five age classes of approxi-
mately equal number: <2, 2 to <5, 5 to<8, 8 to <11
and 11 years of age.
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Group 1 consisted of 113 cats with uveitis. Of the
cats, 42 were from low flea risk states, 65 were
from high flea risk states, and state was un-
known for seven cats. Bartonella species seropre-
valence was 54.9% (62 of 113 cats) with titers
ranging from 0 to 1:512 and a median titer of
1:64.
Group 2 (clinically ill cats without ocular dis-
ease noted) consisted of 156 cats. Of the cats, 60
were from low flea risk states, 92 were from
high risk states, and state was unknown for
four cats. Bartonella species seroprevalence rate
was 62.8% (98 of 156 cats) with titers ranging
from 0 to 1:1024 and a median titer of 1:64.
Group 3 (healthy cats) consisted of 97 cats. Of
the cats, 26 were from low flea risk states, 70
were from high risk states, and state was un-
known for one cat. Bartonella species seropreva-
lence rate was 70.1% (68 of 97 cats) with titers
ranging from 0 to 1:8192 and a median titer of
1:64.
In the initial statistical evaluation, group 3 cats
had a greater seropositive rate than group 1 cats
(Table 1, P¼ 0.0322). After the addition of vari-
ables (age and risk of flea exposure), the effect
of group was still significant (P¼ 0.0126). The
likelihood of being seropositive for Bartonella spe-
cies increased with higher flea risk (P< 0.0001;
odds ratio (OR)¼ 2.731) but decreased as age in-
creased (P¼ 0.0035; OR¼ 0.779) (Table 2).Table 1. Relationships between Bartonella hen-
selae seroprevalence rates among cats with uve-
itis (group 1), ill cats without recorded ocular
disease (group 2), and healthy cats (group 3)
Seroprevalence number
of positives (%)
P value*
Group 1 (n¼ 113) 62 (54.9%)
Group 2 (n¼ 156) 98 (62.8%) 0.2094
Group 3 (n¼ 97) 68 (70.1%) 0.0322
*Fisher’s exact test was used to compare group 1 to
group 2 and group 1 to group 3.Median titers were equal among groups; how-
ever, Wilcoxon’s rank sum test revealed that the
mean rank of titers in group 3 was significantly
greater than that in group 1 (P¼ 0.0024). Figure 1
provides a bar graph of the distribution of Barto-
nella species antibody titers.Discussion
Due to its retrospective nature, there are several
limitations to this study. Samples were submitted
by multiple veterinary clinicians (both board cer-
tified ophthalmologists and general practi-
tioners) and the motivation to submit sera for
testing differed among groups. Thus one of the
major weaknesses of this study is the lack of
a consistent ophthalmic examination among
cases. It is possible that the eyes of some cats in
the control groups were not extensively exam-
ined and may have had uveitis. This difference
between groups may be heightened as cats in
group 1 were presented for ophthalmic disease
and were examined by a board certified0
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Fig 1. Distribution of Bartonella species antibody titers in
cats with or without uveitis. Group 1: cats with uveitis, group
2: ill cats without ocular disease noted, and group 3: healthy
cats. The serum Bartonella species titer for one cat in group 3
was 1:8192. This value was not included in the graph.
44 JP Fontenelle et alophthalmologist, whereas those in groups 2 and
3 were not. In addition, the complete medical re-
cord was not available; therefore, the ophthalmic
findings could not be used to accurately classify
cats as having anterior uveitis, posterior uveitis,
or panuveitis. Due to the association between
flea infestation and B henselae, cats in this study
were classified into high or low flea risk cate-
gories by geographic location (state) and it was
shown that presence of Bartonella species anti-
bodies was associated with high flea risk. How-
ever, knowledge of the physical presence of
fleas would have been more accurate as flea
prevalence can vary within states and can also
be dependent upon the housing status of indi-
vidual cats (indoor vs outdoor). Lastly, because
there is serological cross-reactivity between B
henselae and other Bartonella species, results of
the antibody test in this study cannot be used
to document specific exposure to B henselae.
However, in most studies that have used culture
or genetic sequencing to evaluate the Bartonella
species causing feline infection in the United
States, B henselae is the most common (Guptill
et al 2004, Lappin et al 2006).
Although most people that are exposed to B
henselae are subclinically infected, cat scratch dis-
ease occurs in a small percentage. Cat scratch
disease was estimated at 9.3 cases per 100,000
people per year in the United States (Jackson
et al 1993). Approximately 5e10% of people with
cat scratch disease are reported to have ocular
manifestations such as Parinaud’s oculoglandu-
lar syndrome, optic neuritis, vitritis, retinitis or
anterior uveitis (Ormerod and Dailey 1999,
Wade et al 2000). It is not known why some peo-
ple develop ocular bartonellosis and others do
not. It may relate to the host response to the or-
ganism (Resto-Ruiz et al 2003). However, it also
may relate to the strain of B henselae as it appears
that some strains are more pathogenic than
others (Woestyn et al 2004). Co-infection with
other agents may also play a role in some cases.
However, cats experimentally coinfected with
T gondii, B henselae, and FHV-1 did not develop
ocular bartonellosis (Powell et al 2002).
As many as 93% of cats in some geographical
regions are seropositive for B henselae with the
highest prevalence in warm, humid climates
that are well suited to support flea populations
(Nutter et al 2004). Due to the high prevalence
of serum antibodies in naturally exposed cats,
it is difficult to determine how many cats de-
velop clinical disease due to Bartonella species
and it is difficult to confirm the diagnosis inindividual cats. For example, in one study of
clinically ill cats in North Carolina, multiple clin-
ical syndromes were assessed for association
with the presence of Bartonella species anti-
bodies. No association was demonstrated for
most abnormalities, including ocular disease
(Breitschwerdt et al 2005). These results indicate
that, as with other causative agents of uveitis (eg,
T gondii, coronaviruses, FHV-1), the presence of
serum antibodies to B henselae does not correlate
with the precise cause of the intraocular inflam-
mation in individual cats (Peiffer and Wilcock
1991). Confirmation of B henselae as the cause of
uveitis has been attempted by locating the organ-
ism’s DNAwithin the eye by PCR and by detect-
ing local antibody production within the eye
(Lappin et al 2000). As Bartonella species is an in-
traerythrocytic bacterium and most cats with
uveitis have some degree of at least microscopic
hyphema, the detection of B henselae DNA in
aqueous humor does not prove ocular infection.
In addition, the organism in erythrocytes could
enter the eye via hemorrhage induced during an-
terior chamber paracentesis. Detection of local
antibody production within the eye can be used
as an indirect method of diagnosing local tissue
infection and has been previously used with
T gondii (Lappin et al 1992), FHV-1 (Maggs et al
1999), and B henselae (Lappin et al 2000). Further
studies of this type are needed on greater num-
bers of cats with and without uveitis in order
to determine if an epidemiologic association be-
tween B henselae and anterior uveitis exists. It is
also possible that comparison of serum and
aqueous humor B henselae antigen recognition
patterns between cats with uveitis and those
without ocular disease could identify improved
diagnostic parameters (Freeland et al 1999).
Using this study design, there was no differ-
ence in seroprevalence between cats with uveitis
and cats with non-ocular diseases; however,
healthy cats were more likely to be seropositive
for Bartonella species than cats with uveitis. Al-
though there was overlap in the magnitude of
serum titers and the median serum titers were
identical (1:64) in all three groups, the healthy
cats were more likely to have higher titers than
cats with uveitis. These results suggest that
Bartonella species antibody titer magnitude is
unlikely to correlate with the presence of disease.
Previous studies have found an increasing pro-
portion of cats seropositive for Bartonella species
with increasing age which may be related to an
increased chance of exposure over time (Chomel
et al 1995, Guptill et al 2004). In this study, the
45Prevalence of serum antibodies against Bartonella specieslikelihood of being seropositive for Bartonella
species decreased with increasing age. It is un-
clear why there are differences between these
studies; they may merely be due to sample selec-
tion. For example, it is possible that older cats in
this study were more likely to be administered
antibiotics or flea control products.
In summary, the results of this study docu-
ment that the presence or magnitude of Bartonella
species serum antibodies cannot be used alone to
document ocular bartonellosis in cats. Until more
sensitive and specific diagnostic tests are identi-
fied, one can only suspect B henselae as a possible
cause of uveitis if B henselae DNA or antibodies
directed against the organism are detected in
blood or aqueous humor, if other known causes
of uveitis are eliminated, and if their clinical
signs resolve following administration of appro-
priate antibiotic therapy.Acknowledgments
The authors express appreciation to the veteri-
narians who submitted samples for this research
and to Jennifer Hawley, Arianne Morris, and
Melissa Brewer for their technical assistance.References
Breitschwerdt EB, Levine JF, Radulovic S, Hanby SB,
Kordick DL, LaPerle KMD (2005) Bartonella henselae and
Rickettsia seroreactivity in a sick cat population from
North Carolina. International Journal of Applied Research in
Veterinary Medicine 3, 287e302.
Brightman AH, Ogilvie GK, Tompkins M (1991) Ocular
disease in FeLV positive cats: 11 cases (1981e1986). Jour-
nal of the American Veterinary Medical Association 198,
1049e1051.
Chomel BB, Abbott RC, Kasten RW, Floyd-Hawkins KA,
Kass PA, Glaser CA, Pedersen NC, Koehler JE (1995)
Bartonella henselae prevalence in domestic cats in Califor-
nia: risk factors and association between bacteremia and
antibody titers. Journal of Clinical Microbiology 33,
2445e2450.
Cunningham ET, Koehler JE (2000) Ocular bartonellosis.
American Journal of Ophthalmology 130, 340e349.
English RV, Davidson MG, Nasisse MP, Jamieson VE,
Lappin MR (1990) Intraocular disease associated with
feline immunodeficiency virus infection in cats. Journal of
the American Veterinary Medical Association 196, 1116e1119.
Freeland RL, Scholl DT, Rohde KR, Shelton LJ, O’Reilly KL
(1999) Identification of Bartonella-specific immunodomi-
nant antigens recognized by the feline humoral immune
system. Clinical and Diagnostic Laboratory Immunology 6,
558e566.
Gerding Jr PA, Morton LD, Dye JA (1994) Ocular and dis-
seminated candidiasis in an immunosuppressed cat. Jour-
nal of the American Veterinary Medical Association 204,
1635e1638.Guptill L, Wu CC, HogenEsch H, Slater LN, Glickman N,
Dunham A, Syme H, Glickman L (2004) Prevalence, risk
factors, and genetic diversity of Bartonella henselae infec-
tions in pet cats in four regions of the United States. Jour-
nal of Clinical Microbiology 42, 652e659.
Jackson LA, Perkins BA,Wenger JD (1993) Cat scratch disease
in theUnited States: an analysis of three national databases.
American Journal of Public Health 83, 1707e1711.
Jameson PH, Greene CE, Regnery RL, Dryden M, Marks A,
Brown J, Cooper J, Glaus B, Greene R (1995) Prevalence of
Bartonella henselae antibodies in pet cats throughout re-
gions of North America. Journal of Infectious Diseases 172,
1145e1149.
Ketring KL, Zuckerman EE, Hardy Jr WD (2004) Bartonella:
a new etiological agent of feline ocular disease. Journal of
the American Animal Hospital Association 40, 6e12.
Kordick DL, Breitschwerdt EB (1995) Intraerythrocytic pres-
ence of Bartonella henselae. Journal of Clinical Microbiology
33, 1655e1656.
Lappin MR, Black JC (1999) Bartonella spp. infection as a pos-
sible cause of uveitis in a cat. Journal of the American Veter-
inary Medical Association 214, 1205e1207.
Lappin MR, Griffin B, Brunt J, Riley A, Burney D, Hawley J,
Brewer MM, Jensen WA (2006) Prevalence of Bartonella
species, haemoplasma species, Ehrlichia species, Ana-
plasma phagocytophilum, and Neorickettsia risticii DNA in
the blood of cats and their fleas in the United States. Jour-
nal of Feline Medicine and Surgery 8, 85e90.
Lappin MR, Kordick DL, Breitschwerdt EB (2000) Bartonella
spp. antibodies and DNA in aqueous humour of cats. Jour-
nal of Feline Medicine and Surgery 2, 61e68.
Lappin MR, Roberts SM, Davidson MG, Powell CC, Reif JS
(1992) Enzyme-linked immunosorbent assays for the de-
tection of Toxoplasma gondii-specific antibodies and anti-
gens in the aqueous humor of cats. Journal of the
American Veterinary Medical Association 201, 1010e1016.
Maggs DJ, Lappin MR, Nasisse MP (1999) Detection of feline
herpesvirus 1 specific antibodies and DNA in the aqueous
humor of cats. American Journal of Veterinary Research 60,
932e936.
Medleau L, Jacobs GJ, Marks MA (1995) Itraconazole for the
treatment of cryptococcosis in cats. Journal of Veterinary In-
ternal Medicine 9, 39e42.
Nutter FB, Dubey JP, Levine JF, Breitschwerdt EB, Ford RB,
Stoskopf MK (2004) Seroprevalences of antibodies against
Bartonella henselae and Toxoplasma gondii and fecal shed-
ding of Cryptosporidium spp., Giardia spp., and Toxocara
cati in feral and domestic cats. Journal of the American Vet-
erinary Medical Association 235, 1394e1398.
Ormerod LD, Dailey JP (1999) Ocular manifestations of cat-
scratch disease. Current Opinion in Ophthalmology 10,
209e216.
Peiffer R, Wilcock B (1991) Histopathologic study of uveitis
in cats: 139 cases (1978e1988). Journal of the American Vet-
erinary Medical Association 198, 135e138.
Powell CC, Kordick DL, Lappin MR (2002) Inoculation with
Bartonella henselae followed by feline herpesvirus 1 fails to
activate ocular toxoplasmosis in chronically infected cats.
Journal of Feline Medicine and Surgery 4, 107e110.
Powell CC, Lappin MR (2001) Causes of feline uveitis. Com-
pendium on Continuing Education for the Practicing Veterinar-
ian 23, 128e141.
Resto-Ruiz S, Burgess A, Anderson BE (2003) The role of the
host immune response in pathogenesis of Bartonella hense-
lae. DNA and Cell Biology 22, 431e440.
46 JP Fontenelle et alRothova A, Kerkoff F, Hooft HJ, Ossewaarde JM (1998) Bar-
tonella serology for patients with intraocular inflammatory
disease. Journal of Retinal and Vitreous Diseases 18, 348e355.
Wade NK, Jones MR, Bhisitkul R, Fine L, Cunningham Jr ET
(2000) Optic disk edema associated with peripapillary
serous retinal detachment: an early sign of systemicBartonella henselae infection. American Journal of Ophthal-
mology 130, 327e334.
Woestyn S, Olive N, Bigaignon G, Avesani V, DelmeeM (2004)
StudyofgenotypesandvirB4secretiongeneofBartonella hen-
selae strains from patients with clinically defined cat scratch
disease. Journal of Clinical Microbiology 42, 1420e1427.Available online at www.sciencedirect.com
